Lisinopril vs Nivolumab

## Lisinopril vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Lisinopril** and **Nivolumab**.

## Mechanism of Action

**Lisinopril**: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Lisinopril — 12 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Lisinopril — C21H31N3O5; Nivolumab — N/A.

**Molecular Weight**: Lisinopril — 405.4900 g/mol; Nivolumab — N/A.

**Type**: Lisinopril — Small molecule; Nivolumab — Antibody.